Philippines vs Saint Vincent and the Grenadines: HPV immunization coverage estimates among primary target cohort (9-14)
Philippines
22.0%
in 2025
Saint Vincent and the Grenadines
18.0%
in 2025
Philippines rank
107th
Saint Vincent and the Grenadines rank
108th
HPV immunization coverage estimates among primary target cohort (9-14) over time
- Philippines
- Saint Vincent and the Grenadines
How they compare
Philippines currently reports 22.0% against 18.0% in Saint Vincent and the Grenadines, a difference of 4.0%.
That makes Philippines's figure about 1.2 times Saint Vincent and the Grenadines's.
Across all 6 years both countries report, Philippines has been ahead every year.
Philippines ranks 107th and Saint Vincent and the Grenadines ranks 108th of 111 countries.
Philippines has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Philippines | Saint Vincent and the Grenadines | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 20.3% | 10.3% | 10.0% | Philippines |
| 2020s | 31.0% | 9.7% | 21.3% | Philippines |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hpv immunization coverage estimates among primary target cohort (9-14), Philippines or Saint Vincent and the Grenadines?
- Philippines, at 22.0% against 18.0% in Saint Vincent and the Grenadines as of 2025.
- What is the difference in hpv immunization coverage estimates among primary target cohort (9-14) between Philippines and Saint Vincent and the Grenadines?
- 4.0%, with Philippines ahead.
- How many years of comparable data are there for Philippines and Saint Vincent and the Grenadines?
- 6 years are reported by both, from 2017 to 2025.
- How do Philippines and Saint Vincent and the Grenadines rank globally for hpv immunization coverage estimates among primary target cohort (9-14)?
- Philippines ranks 107th and Saint Vincent and the Grenadines ranks 108th of 111 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HPV immunization coverage estimates among primary target cohort (9-14 years old girls) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.